GlaxoSmithKline Pakistan Balance Sheet Health
Financial Health criteria checks 5/6
GlaxoSmithKline Pakistan has a total shareholder equity of PKR21.7B and total debt of PKR572.9M, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are PKR38.1B and PKR16.5B respectively. GlaxoSmithKline Pakistan's EBIT is PKR2.0B making its interest coverage ratio -7.3. It has cash and short-term investments of PKR3.6B.
Key information
2.6%
Debt to equity ratio
PK₨572.93m
Debt
Interest coverage ratio | -7.3x |
Cash | PK₨3.61b |
Equity | PK₨21.68b |
Total liabilities | PK₨16.46b |
Total assets | PK₨38.13b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GLAXO's short term assets (PKR25.3B) exceed its short term liabilities (PKR14.6B).
Long Term Liabilities: GLAXO's short term assets (PKR25.3B) exceed its long term liabilities (PKR1.9B).
Debt to Equity History and Analysis
Debt Level: GLAXO has more cash than its total debt.
Reducing Debt: GLAXO's debt to equity ratio has increased from 0% to 2.6% over the past 5 years.
Debt Coverage: GLAXO's debt is well covered by operating cash flow (278.4%).
Interest Coverage: GLAXO earns more interest than it pays, so coverage of interest payments is not a concern.